关键词: Staphylococcus aureus adhesive contact dermatitis epidural abscess spinal cord stimulator trial surgical site infection

来  源:   DOI:10.1080/17581869.2024.2373044

Abstract:
We present a case of deep surgical site infection (SSI) at a spinal cord stimulator (SCS) trial implantation site, resulting from an allergic reaction to an unknown agent. A 38-year-old female with complex regional pain syndrome began an SCS trial, noting 100% pain relief for 5 days. Fluid drainage from the surgical site was reported on POD6 and trial leads were removed the following day. The patient was hospitalized with sepsis. Blood cultures revealed Staphylococcus aureus. MRIs showed skin breakdown and cellulitis of the paraspinal musculature extending into the epidural space. The patient was maintained with antibiotics and rigorous wound care for 9 days and the surgical site infection resolved. The patient proceeded to SCS implantation, and reported good pain relief with the implanted device.
This case report describes the treatment of an infection developed during a spinal cord stimulator (SCS) trial period. SCS are medical devices used to treat pain, they work by applying electrical current to the areas of the spinal cord that cause patients’ pain. Before patients get an SCS device implanted, they often undergo a trial period first. During a trial, the stimulator device stays outside the body, and only the wires carrying electricity to the spinal cord are implanted. Typically, SCS trial and implantation procedures are safe and result in effective pain relief. However, infections are a dangerous potential complication that can result from these procedures. In our case, the patient developed an infection during an SCS trial period, likely resulting from an allergic reaction to their surgical dressings. The infection traveled down the wires and nearly reached the spinal cord. Since the infection was quickly identified and managed, devastating complications were avoided. The patient was able to get a permanent SCS after the infection was resolved, and had effective pain relief. Our report emphasizes the importance of using strict infection prevention techniques, and monitoring patients for signs of infection throughout SCS trials.
摘要:
我们介绍了一例脊髓刺激器(SCS)试验植入部位的深部手术部位感染(SSI),对未知病原体的过敏反应导致的.一名患有复杂区域疼痛综合征的38岁女性开始了一项SCS试验,注意100%疼痛缓解5天。在POD6上报告了手术部位的液体引流,第二天取出试验导线。患者因脓毒症住院。血培养显示金黄色葡萄球菌。MRI显示椎旁肌肉组织的皮肤破裂和蜂窝织炎延伸到硬膜外腔。患者用抗生素和严格的伤口护理维持9天,手术部位感染解决。患者进行SCS植入,据报道,植入装置的疼痛缓解效果良好。
本病例报告描述了脊髓刺激器(SCS)试验期间发生的感染的治疗方法。SCS是用于治疗疼痛的医疗设备,他们的工作原理是将电流施加到导致患者疼痛的脊髓区域。在患者植入SCS设备之前,他们通常先经历一个试用期。在审判期间,刺激器装置停留在体外,只有输送电力到脊髓的电线被植入。通常,SCS试验和植入程序是安全的,可有效缓解疼痛。然而,感染是一种危险的潜在并发症,可导致这些程序。在我们的案例中,患者在SCS试验期间出现感染,可能是由于对其外科敷料的过敏反应。感染沿着电线向下传播,几乎到达脊髓。由于感染很快被识别和控制,避免了毁灭性的并发症。感染解决后,患者能够获得永久性SCS,并有效缓解疼痛。我们的报告强调了使用严格的感染预防技术的重要性,并在整个SCS试验中监测患者的感染迹象。
公众号